EASD 2023 Testosterone Audit - Poster
Testosterone replacement in men with Type 2 Diabetes lowers HbA1c
ABCD Worldwide Audit of Testosterone and Diabetes.
Authors:
H.Jones, K. Darzy, R. Troke, U. Dashora, A. Haider, R. Ryder
Testosterone replacement in men with Type 2 Diabetes lowers HbA1c
ABCD Worldwide Audit of Testosterone and Diabetes.
Authors:
H.Jones, K. Darzy, R. Troke, U. Dashora, A. Haider, R. Ryder
Is hybrid closed-loop therapy associated with weight gain? Results from the ABCD Closed-Loop audit of the NHS England Pilot
Authors: TSJ Crabtree; TP Griffin; YW Yap; P Narendran; G Gallen; J Elliott; MA Karamat; S Saraf; L Leelarathna; S Hussain; A Lumb; REJ Ryder; P Choudhary; EG Wilmot on behalf of all ABCD Closed-Loop Pilot audit contributors
Diabetes distress and quality of life in individuals using hybrid closed-loop therapy as part of the NHS England pilot: Results from the ABCD audit.
Authors:
TSJ Crabtree; TP Griffin; YW Yap; P Narendran; G Gallen; J Elliott; MA Karamat; S Saraf; L Leelarathna; S Hussain; A Lumb; REJ Ryder; P Choudhary; EG Wilmot on behalf of all ABCD Closed-Loop Pilot audit contributors
To shine a light on the funding available for diabetes research from ABCD, we're speaking to those who were awarded a Diabetes Care Trust and ABCD Research Grant.
In our first interview we hear from Gordon Sloan, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust who was awarded funding for his project exploring potential brain imaging biomarkers of Painful-Diabetic Peripheral Neuropathy (DPN).
Please note that the ABCD Conference 2024 programme is subject to change
We welcome abstracts on any subject relating to Diabetes, Endocrinology and General Medicine, which might be o
Duodenal Jejunal bypass liner for Diabesity – Risk versus benefit data from the Association of British Clinical Diabetologists (ABCD) Worldwide EndoBarrier Registry.
Authors: B. Ryder, M. Lynne, H. Frydenberg, S. Fishman, R. Cohen, C. de Jonge, J. Greve, J. Bascomb, J. Bessell, J. McMaster, G. Holtman, G. Rich, J. Collins, L. Kow, P. Pferschy, H. Sourij, J. Byrne, J. Mason, J. Teare, M. Benes
UK first National Health Service (NHS) EndoBarrier Service for uncontrolled Diabesity shows the metabolic improvements 6-months after EndoBarrier removal are well maintained.
Authors: REJ Ryder, M Yadagiri, SP Irwin, W Burbridge, T Bashir, MC Wyres, ML Cull, JP Bleasdale, RA Allden, EN Fogden, M Anderson and P Sen Gupta
Impact of Endobarrier on need for Continuous Positive Airway Pressure Ventilation(CPAP) in Diabetes/Pre-Diabetes with Obstructive sleep apnoea(OSA) study: Current data at Endobarrier removal and 6-months later.
Authors: M Yadagiri, F Kinney, J Adams, N. Ashman, JP Bleasdale, EN Fogden, MR Anderson, M Greenstone, C Walton, REJ Ryder